Cargando…

Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity

HIV-associated neurocognitive disorders (HAND) affect about 50% of infected patients despite combined antiretroviral therapy (cART). Ongoing compartmentalized inflammation mediated by microglia which are activated by HIV-infected monocytes has been postulated to contribute to neurotoxicity independe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ambrosius, Björn, Faissner, Simon, Guse, Kirsten, von Lehe, Marec, Grunwald, Thomas, Gold, Ralf, Grewe, Bastian, Chan, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346211/ https://www.ncbi.nlm.nih.gov/pubmed/28284222 http://dx.doi.org/10.1186/s12974-017-0829-2

Ejemplares similares

Fingolimod Augments Monomethylfumarate Killing of GBM Cells
por: Dent, Paul, et al.
Publicado: (2020)

Antineuroinflammatory drugs in HIV-associated neurocognitive disorders as potential therapy
por: Ambrosius, Björn, et al.
Publicado: (2019)

Corrigendum: Fingolimod Augments Monomethylfumarate Killing of GBM Cells
por: Dent, Paul, et al.
Publicado: (2020)

Functional relevance of the multi-drug transporter abcg2 on teriflunomide therapy in an animal model of multiple sclerosis
por: Thiele née Schrewe, Lisa, et al.
Publicado: (2020)

The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies
por: Freedman, Mark S, et al.
Publicado: (2017)

Teriflunomide – The common drug with underestimated oxygen - Dependent anticancer potential
por: Otto-Ślusarczyk, Dagmara, et al.
Publicado: (2021)

Teriflunomide Does Not Change Dynamics of Nadph Oxidase Activation and Neuronal Dysfunction During Neuroinflammation
por: Mothes, Ronja, et al.
Publicado: (2020)

Teriflunomide treatment exacerbates cardiac ischemia reperfusion injury in isolated rat hearts
por: Alexander, Emily Davis, et al.
Publicado: (2022)

Comparison of Neuroprotective Effects of Monomethylfumarate to the Sigma 1 Receptor Ligand (+)-Pentazocine in a Murine Model of Retinitis Pigmentosa
por: Xiao, Haiyan, et al.
Publicado: (2020)

Teriflunomide attenuates neuroinflammation-related neural damage in mice carrying human PLP1 mutations
por: Groh, Janos, et al.
Publicado: (2018)

In vivo detection of teriflunomide-derived fluorine signal during neuroinflammation using fluorine MR spectroscopy
por: Prinz, Christian, et al.
Publicado: (2021)

Clinical efficacy of teriflunomide over a fixed 2-year duration in the TOWER study
por: Freedman, Mark S, et al.
Publicado: (2018)

Methamphetamine neurotoxicity, microglia, and neuroinflammation
por: Shaerzadeh, Fatemeh, et al.
Publicado: (2018)

Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis
por: Comi, Giancarlo, et al.
Publicado: (2020)

Induction of Neuroinflammation and Neurotoxicity by Synthetic Hemozoin
por: Velagapudi, Ravikanth, et al.
Publicado: (2019)

Clozapine Regulates Microglia and Is Effective in Chronic Experimental Autoimmune Encephalomyelitis
por: Ceylan, Ulaş, et al.
Publicado: (2021)

Oxidative Stress Is Associated with Neuroinflammation in Animal Models of HIV-1 Tat Neurotoxicity
por: Louboutin, Jean-Pierre, et al.
Publicado: (2014)

Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
por: Hammer, Anna, et al.
Publicado: (2017)

In vitro evaluation of the activity of teriflunomide against SARS-CoV-2 and the human coronaviruses 229E and OC43
por: Lang, Paul, et al.
Publicado: (2022)

Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
por: Chan, Andrew, et al.
Publicado: (2016)

Methamphetamine-Induced Neuronal Damage: Neurotoxicity and Neuroinflammation
por: Kim, Buyun, et al.
Publicado: (2020)

An update of teriflunomide for treatment of multiple sclerosis
por: Oh, Jiwon, et al.
Publicado: (2013)

Teriflunomide promotes oligodendroglial differentiation and myelination
por: Göttle, Peter, et al.
Publicado: (2018)

Teriflunomide: Lack of efficacy: case report
Publicado: (2022)

Lichenoid Drug Eruption Induced by Teriflunomide
por: Agharbi, Fatima-Zahra, et al.
Publicado: (2023)

Painful Small Fiber Neuropathy Associated With Teriflunomide: A Case Series and Literature Review Related to Teriflunomide and Leflunomide
por: Elrefaey, Ahmed, et al.
Publicado: (2023)

Features of Microglia and Neuroinflammation Relevant to Environmental Exposure and Neurotoxicity
por: Kraft, Andrew D., et al.
Publicado: (2011)

Cellular and Molecular Mechanisms Mediating Methylmercury Neurotoxicity and Neuroinflammation
por: Novo, João P., et al.
Publicado: (2021)

Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
por: Bar-Or, Amit, et al.
Publicado: (2014)

Role of oral teriflunomide in the management of multiple sclerosis
por: Tanasescu, Radu, et al.
Publicado: (2013)

Teriflunomide as a therapeutic means for myelin repair
por: Göttle, Peter, et al.
Publicado: (2023)

Neuropathy in multiple sclerosis patients treated with teriflunomide
por: Kilic, Ahmet Kasim, et al.
Publicado: (2023)

No evidence for interactions of dimethylfumarate (DMF) and its main metabolite monomethylfumarate (MMF) with human cytochrome P450 (CYP) enzymes and the P‐glycoprotein (P‐gp) drug transporter
por: Aubets, Jordi, et al.
Publicado: (2019)

Extracranial glioblastoma with synchronous metastases in the lung, pulmonary lymph nodes, vertebrae, cervical muscles and epidural space in a young patient - case report and review of literature
por: Blume, Christian, et al.
Publicado: (2013)

Specific relations of visual skills and executive functions in elite soccer players
por: Knöllner, Antonia, et al.
Publicado: (2022)

Review of teriflunomide and its potential in the treatment of multiple sclerosis
por: Warnke, Clemens, et al.
Publicado: (2009)

Teriflunomide treatment reduces B cells in patients with MS
por: Gandoglia, Ilaria, et al.
Publicado: (2017)

COVID-19 in teriflunomide-treated patients with multiple sclerosis
por: Maghzi, Amir Hadi, et al.
Publicado: (2020)

Teriflunomide Safety and Efficacy in Advanced Progressive Multiple Sclerosis
por: Moreira Ferreira, Vanessa F., et al.
Publicado: (2020)

Vaccine Response in Patients With Multiple Sclerosis Receiving Teriflunomide
por: Tornatore, Carlo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jrmd3g2v1jjr4789legvurgm5q